Transcriptomic Profiling Reveals Distinct Immune Dysregulation in Early-Stage Sepsis Patients

Area of Science:

• Immunology
• Genomics
• Transcriptomics

Background:

• Sepsis is a life-threatening condition driven by dysregulated immune responses to infection.
• Understanding early transcriptional alterations is crucial for sepsis management.

Purpose of the Study:

• To identify early gene expression changes in sepsis patients.
• To provide transcriptomic insights for developing diagnostic biomarkers and therapeutic targets.

Main Methods:

• Case-control study profiling whole blood gene expression in 20 early-stage sepsis patients and 9 healthy controls.
• Utilized Affymetrix Clariom D Human Arrays and standard bioinformatic pipelines for differential gene expression analysis.

Main Results:

• Identified 344 upregulated and 9703 downregulated genes in sepsis patients (|log2FC| > 1, adjusted p < 0.05).
• Pathway analysis revealed activation of innate immunity, neutrophil degranulation, and cytokine signaling.
• Observed suppression of lymphocyte differentiation and antigen presentation pathways.

Conclusions:

• Early sepsis is characterized by a transcriptional shift towards an innate immune-driven inflammatory state.
• These findings highlight potential transcriptomic biomarkers for early sepsis detection.
• The identified gene expression patterns may inform the development of novel sepsis therapies.